PT-141 Nasal Spray Safely Induces Erection in Both Healthy Men and ED Patients | Research

The takeaway

Intranasal PT-141 (bremelanotide) safely induced erections in healthy men and Viagra-responsive ED patients in a double-blind placebo-controlled trial, validating melanocortin-based intranasal erectile dysfunction therapy.

Brain-based nasal spray
Intranasal PT-141 induced erections through brain melanocortin receptors — a non-invasive alternative working through desire rather than blood flow

What the researchers found

Intranasal PT-141 induced dose-dependent erectile responses in both healthy men and Viagra-responsive ED patients in a double-blind, placebo-controlled trial, with rapid onset and acceptable safety — validating intranasal melanocortin ED therapy.

Why it matters

PT-141's intranasal delivery offers a non-invasive alternative to injections. Its brain-based mechanism helps patients where Viagra (which works on blood flow) is insufficient — addressing desire, not just mechanics.

How the study worked

Double-blind, placebo-controlled, dose-escalation study. PT-141 intranasal spray in healthy males and Viagra-responsive ED patients. Erectile response (RigiScan), pharmacokinetics, and safety measured.

What this study cannot tell us

Viagra-responsive ED patients (mild ED). Results may differ in severe ED or Viagra-non-responders. Nausea at higher doses limits dose escalation.

How to read the evidence

Moderate evidence from a well-designed double-blind, placebo-controlled dose-escalation study in two relevant populations.

When this study was published

Published in 2004. PT-141 development continued, leading to FDA approval as Vyleesi (SC injection) for female sexual desire disorder in 2019.

The bigger picture

PT-141 later became FDA-approved as Vyleesi (for female sexual desire). This male ED study validated the intranasal melanocortin approach that informed its clinical development path.

Questions still open

Can PT-141 help Viagra-non-responders?
What is the optimal intranasal dose balancing efficacy and nausea?
Could combination PT-141 + PDE5 inhibitor address both desire and blood flow?

Common questions

How is PT-141 different from Viagra?

Viagra works on blood flow to the penis. PT-141 works on the brain's desire centers through melanocortin receptors. It addresses WANTING to have sex, not just the physical mechanics.

Is a nasal spray practical for ED?

This study showed it works — rapid absorption, peak effect in 1-2 hours, and significant erectile responses. The nasal route is non-invasive and discreet.

Read the original research

Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction.

International journal of impotence research, 16(1), 51-9

View on PubMed ↗

Citation

Diamond, L E; Earle, D C; Rosen, R C; Willett, M S; Molinoff, P B. (2004). Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction.. International journal of impotence research, 16(1), 51-9.